CAS ANNOUNCES FDA 510(K) CLEARANCE FOR EXPANDED USE OF FORE-SIGHT(TM) CEREBRAL OXIMETER

CAS Medical Systems announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded use of its FORE-SIGHT Absolute Cerebral Oximeter in additional patient populations including children over 40 kg and infants.
CASMed